Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

Shenton Research

Shenton Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Quantitative Analysis

<ul>
<li>We analysed the earning revision of component stocks of HSCEI in the past month.</li>
<li>We tabulated stocks with the top impact on index's EPS, stocks' EPS revision, and revenue revision.</li>
<li>We highlighted EPS revision on Kuaishou, PING AN, CHINA LIFE, XPENG, XIAOMI, BIDU, BEONE MEDICINES, LI AUTO.</li>
</ul>


We analysed the earning revision of component stocks of HSCEI in the past month.
We tabulated stocks with the top impact on index's EPS, stocks' EPS revision, and revenue revision.
We highlighted EPS revision on Kuaishou, PING AN, CHINA LIFE, XPENG, XIAOMI, BIDU, BEONE MEDICINES, LI AUTO.


HSCEI Index Earning Revision (Aug): Kuaishou, PING AN, CHINA LIFE, XPENG, XIAOMI, BIDU, LI AUTO

<ul>
<li>We analysed the earning revision of component stocks of HSI in the past month.</li>
<li>We tabulated stocks with the top impact on index's EPS, stocks' EPS revision, and revenue revision.</li>
<li>We highlighted EPS revision on XINYI SOLAR, Kuaishou, CK HUTCHISON, PING AN, CHINA LIFE, XIAOMI, LI AUTO, BEONE MEDICINES.</li>
</ul>


We analysed the earning revision of component stocks of HSI in the past month.
We tabulated stocks with the top impact on index's EPS, stocks' EPS revision, and revenue revision.
We highlighted EPS revision on XINYI SOLAR, Kuaishou, CK HUTCHISON, PING AN, CHINA LIFE, XIAOMI, LI AUTO, BEONE MEDICINES.


HSI Index Earning Revision (Aug): XINYI SOLAR, Kuaishou, CK HUTCHISON, PING AN, CHINA LIFE, XIAOMI

<ul>
<li>We analyze the weekly Hong Kong Connect flows with our data engine for holding position as of August 28th.</li>
<li>The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.</li>
<li>We highlight flows for Alibaba, Smic, Hua Hong Semi, Akeso, Yofc, Cspc Pharma, Innovent Bio, Minimax, Kuaishou, Ping An.</li>
</ul>


We analyze the weekly Hong Kong Connect flows with our data engine for holding position as of August 28th.
The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.
We highlight flows for Alibaba, Smic, Hua Hong Semi, Akeso, Yofc, Cspc Pharma, Innovent Bio, Minimax, Kuaishou, Ping An.


HK Connect Flows Weekly (Aug 28th): Alibaba, Smic, Hua Hong Semi, Akeso, Yofc, Cspc Pharma, Minimax

Founder-CEO & Chief Analyst, Real Estate Foresight

Robert Ciemniak

Founder-CEO & Chief Analyst

Real Estate Foresight

Since 2012, REF has been helping investors with market research, project due diligence, and strategy development. This has ranged from detailed assessments and estimates on distressed developers' project portfolios to market due diligence on specific projects to macro-level questions linked to demand for commodities. The unique combination of the housing markets and developer data from data partner China Index Academy in Beijing, primary research, and technology-powered alternative data collection from public sources result in a valuable content set used in REF analytics and reports.

Predictive Analytics for China Property

Thematic (Sector/Industry)

<ul>
<li>In this note, we share highlights from our 12th annual China Property Outlook, the 2024 forecasts for China housing markets, and the core themes</li>
<li>The main 2024 scenarios: NBS national 'commercial residential' new home sales in GFA terms to decline by 3.5% (less negative vs -8.2% for 2023), new starts by 10%</li>
<li>The shift in demand from primary to secondary markets, the 'three major projects', greater divergence between cities, and support for developers, are our core themes for 2024</li>
</ul>


In this note, we share highlights from our 12th annual China Property Outlook, the 2024 forecasts for China housing markets, and the core themes
The main 2024 scenarios: NBS national 'commercial residential' new home sales in GFA terms to decline by 3.5% (less negative vs -8.2% for 2023), new starts by 10%
The shift in demand from primary to secondary markets, the 'three major projects', greater divergence between cities, and support for developers, are our core themes for 2024


Highlights from the 12th Annual China Property Outlook - 2024 Forecast

Macroeconomics

<ul>
<li>We look at the key annual macro-property data for 2011-2023 and review the past 'group forecasts' for new home sales in China in 2023 and 2022</li>
<li>The views in 2023 proved more in line with the actual than in 2022 but NBS revisions to 2022 new home sales data (Mar-Dec) add some complications</li>
<li>You can <a href="https://ref.kubrosearch.com/drawkits/index.html" target="_blank" rel="noopener">join this year's 'draw the line'</a> for new home sales, part of Real Estate Foresight's 12th Annual China Property Outlook</li>
</ul>


We look at the key annual macro-property data for 2011-2023 and review the past 'group forecasts' for new home sales in China in 2023 and 2022
The views in 2023 proved more in line with the actual than in 2022 but NBS revisions to 2022 new home sales data (Mar-Dec) add some complications
You can join this year's 'draw the line' for new home sales, part of Real Estate Foresight's 12th Annual China Property Outlook


China Property: In Hindsight On 2023 and 2022 Forecasts | "Draw The Line" 2024

Hong Kong

China Overseas Land & Investment is a Hong Kong-based real estate conglomerate primarily engaged in property development and sales, property investment, and property management services. The company develops residential and commercial properties, including office buildings, shopping malls, and hotels. It was founded in Hong Kong in 1979.

China Overseas Land & Investment (688 HK)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

China Overseas Land & Investment (688 HK)

HSCEI Index Earning Revision (Aug): Kuaishou, PING AN, CHINA LIFE, XPENG, XIAOMI, BIDU, LI AUTO

We analyzed HSCEI's consensus for Aug 2026 and highlighted changes of EPS in Kuaishou, PING AN, CHINA LIFE, XPENG, XIAOMI, BIDU, BEONE MEDICINES,...

Ke Yan, CFA, FRM

HSI Index Earning Revision (Aug): XINYI SOLAR, Kuaishou, CK HUTCHISON, PING AN, CHINA LIFE, XIAOMI

We analyzed HSI's consensus for Aug 2026 and highlighted changes of EPS in XINYI SOLAR, Kuaishou, CK HUTCHISON, PING AN, CHINA LIFE, XIAOMI, LI...

Ke Yan, CFA, FRM

HK Connect Flows Weekly (Aug 28th): Alibaba, Smic, Hua Hong Semi, Akeso, Yofc, Cspc Pharma, Minimax

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Alibaba, Smic, Hua Hong Semi, Akeso, Yofc, Cspc Pharma,...

Ke Yan, CFA, FRM

Highlights from the 12th Annual China Property Outlook - 2024 Forecast

In this note, we share highlights from our 12th annual China Property Outlook, the 2024 forecasts for China housing markets, and the core themes.

Robert Ciemniak

China Property: In Hindsight On 2023 and 2022 Forecasts | "Draw The Line" 2024

Before getting into the forecasts for 2024, reviewing how the past forecasts fared vs the actuals can be quite illuminating, here is the case for...

Robert Ciemniak

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)